These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 9804761)
1. Selective inhibition of factor Xa in the prothrombinase complex by the carboxyl-terminal domain of antistasin. Mao SS; Przysiecki CT; Krueger JA; Cooper CM; Lewis SD; Joyce J; Lellis C; Garsky VM; Sardana M; Shafer JA J Biol Chem; 1998 Nov; 273(46):30086-91. PubMed ID: 9804761 [TBL] [Abstract][Full Text] [Related]
2. Anticoagulant effects of the selective factor XA inhibitors tick anticoagulant peptide and antistasin in the APTT assay are determined by the relative rate of prothrombinase inhibition. Dunwiddie CT; Smith DE; Nutt EM; Vlasuk GP Thromb Res; 1991 Dec; 64(6):787-94. PubMed ID: 1798970 [No Abstract] [Full Text] [Related]
3. Antistasin, a leech-derived inhibitor of factor Xa. Kinetic analysis of enzyme inhibition and identification of the reactive site. Dunwiddie C; Thornberry NA; Bull HG; Sardana M; Friedman PA; Jacobs JW; Simpson E J Biol Chem; 1989 Oct; 264(28):16694-9. PubMed ID: 2777803 [TBL] [Abstract][Full Text] [Related]
4. Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor. Lockett JM; Mast AE Biochemistry; 2002 Apr; 41(15):4989-97. PubMed ID: 11939795 [TBL] [Abstract][Full Text] [Related]
5. Anticoagulant potential of synthetic and recombinant inhibitors of factor Xa and thrombin in vitro. Hauptmann J; Kaiser B Blood Coagul Fibrinolysis; 1993 Aug; 4(4):577-82. PubMed ID: 8218854 [TBL] [Abstract][Full Text] [Related]
6. Interaction of antistasin-related peptides with factor Xa: identification of a core inhibitory sequence. Ohta N; Brush M; Jacobs JW Thromb Haemost; 1994 Dec; 72(6):825-30. PubMed ID: 7740449 [TBL] [Abstract][Full Text] [Related]
7. X-ray structure of antistasin at 1.9 A resolution and its modelled complex with blood coagulation factor Xa. Lapatto R; Krengel U; Schreuder HA; Arkema A; de Boer B; Kalk KH; Hol WG; Grootenhuis PD; Mulders JW; Dijkema R; Theunissen HJ; Dijkstra BW EMBO J; 1997 Sep; 16(17):5151-61. PubMed ID: 9311976 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and structure-activity relationship of a series of fragment analogues of antistasin (ATS) and ghilantens (GLS). Danalev DL; Vezenkov LT; Grigorova B Bioorg Med Chem Lett; 2005 Oct; 15(19):4217-20. PubMed ID: 16084083 [TBL] [Abstract][Full Text] [Related]
9. Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor. Franssen J; Salemink I; Willems GM; Wun TC; Hemker HC; Lindhout T Biochem J; 1997 Apr; 323 ( Pt 1)(Pt 1):33-7. PubMed ID: 9173898 [TBL] [Abstract][Full Text] [Related]
10. Site-directed mutagenesis of the leech-derived factor Xa inhibitor antistasin. Probing of the reactive site. Hofmann KJ; Nutt EM; Dunwiddie CT Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):943-9. PubMed ID: 1445252 [TBL] [Abstract][Full Text] [Related]
11. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va. Heeb MJ; Kojima Y; Hackeng TM; Griffin JH Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912 [TBL] [Abstract][Full Text] [Related]
12. Anticoagulant and antithrombotic action of the factor Xa inhibitor antistasin (ATS). Hauptmann J; Kaiser B Thromb Res; 1993 Jul; 71(2):169-74. PubMed ID: 8362380 [No Abstract] [Full Text] [Related]
13. Purification and characterization of recombinant antistasin: a leech-derived inhibitor of coagulation factor Xa. Nutt EM; Jain D; Lenny AB; Schaffer L; Siegl PK; Dunwiddie CT Arch Biochem Biophys; 1991 Feb; 285(1):37-44. PubMed ID: 1990979 [TBL] [Abstract][Full Text] [Related]
14. Characterization of recombinant antistasin secreted by Saccharomyces cerevisiae. Przysiecki CT; Joyce JG; Keller PM; Markus HZ; Carty CE; Hagopian A; Sardana MK; Dunwiddie CT; Ellis RW; Miller WJ Protein Expr Purif; 1992 Jun; 3(3):185-95. PubMed ID: 1392615 [TBL] [Abstract][Full Text] [Related]
15. Expression and characterization of the N-terminal half of antistasin, an anticoagulant protein derived from the leech Haementeria officinalis. Palladino LO; Tung JS; Dunwiddie C; Alves K; Lenny AB; Przysiecki C; Lehman D; Nutt E; Cuca GC; Law SW Protein Expr Purif; 1991 Feb; 2(1):37-42. PubMed ID: 1821771 [TBL] [Abstract][Full Text] [Related]
16. Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C. Mesters RM; Heeb MJ; Griffin JH Protein Sci; 1993 Sep; 2(9):1482-9. PubMed ID: 8401232 [TBL] [Abstract][Full Text] [Related]
17. The hydrolysis and resynthesis of a single reactive site peptide bond in recombinant antistasin by coagulation factor Xa. Dunwiddie CT; Vlasuk GP; Nutt EM Arch Biochem Biophys; 1992 May; 294(2):647-53. PubMed ID: 1567219 [TBL] [Abstract][Full Text] [Related]
18. Structure of the complex of the antistasin-type inhibitor bdellastasin with trypsin and modelling of the bdellastasin-microplasmin system. Rester U; Bode W; Moser M; Parry MA; Huber R; Auerswald E J Mol Biol; 1999 Oct; 293(1):93-106. PubMed ID: 10512718 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of inhibition of the prothrombinase complex by a covalent antithrombin-heparin complex. Stevic I; Berry LR; Chan AK J Biochem; 2012 Aug; 152(2):139-48. PubMed ID: 22518847 [TBL] [Abstract][Full Text] [Related]
20. Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex. Deguchi H; Takeya H; Gabazza EC; Nishioka J; Suzuki K Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):729-35. PubMed ID: 9032460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]